Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):280–288. doi: 10.1097/QAI.0b013e31828a292c

FIGURE 1.

FIGURE 1

Urinary thromboxane is higher in HIV-infected subjects and is less responsive to aspirin therapy. A, Urinary 11-dehydro-TXB2 levels were higher in HIV(+) subjects as compared to HIV(−) control subjects at baseline, (*P = 0.02) and after 1 week of aspirin (*P = 0.04), Mann– Whitney test. B, Plasma P-selectin levels decreased in ART-treated HIV-infected subjects after 1 week of aspirin, paired t test, *P < 0.05. P-selectin levels do not decrease in uninfected control subjects after 1 week of aspirin.

HHS Vulnerability Disclosure